FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893062761> ?p ?o ?g. }

• W2893062761 endingPage "636" @default.
• W2893062761 startingPage "628" @default.
• W2893062761 abstract "Abstract CSL112 (Apolipoprotein A‐I [human]) is an intravenous preparation of apolipoprotein A‐I (apoA‐I), formulated with phosphatidylcholine (PC) and stabilized with sucrose, in development to prevent early recurrent cardiovascular events following acute myocardial infarction (AMI). This phase 1 study was designed to determine if moderate renal impairment (RI) influenced the pharmacokinetics (PK) and safety of CSL112. Thirty‐two subjects, 16 with moderate RI (estimated glomerular filtration rate [eGFR] ≥ 30 and < 60 mL/min/1.73 m 2 ) and 16 age‐, sex‐, and weight‐matched subjects with normal renal function (eGFR ≥ 90 mL/min/1.73 m 2 ) were randomized 3:1 to receive a single infusion of CSL112 2 g (n = 6) or placebo (n = 2), or CSL112 6 g (n = 6) or placebo (n = 2). PK sampling was at prespecified times from 48 hours prior to 144 hours following infusions, with final safety assessments at 90 days. Renal and hepatic safety, and adverse events (AEs) were monitored throughout the study. Plasma apoA‐I and PC PK profiles were similar between renal function cohorts at both doses. For CSL112 6 g mean ± SD apoA‐I AUC 0 ‐ last was 7670 ± 1900 and 9170 ± 2910 mg·h/dL in normal renal function and moderate RI subjects, respectively. Renal apoA‐I clearance was <1% of CSL112 dose. In moderate RI, sucrose clearance was slower; however, approximately 70% was excreted within 48 hours in both renal function cohorts. No CSL112‐related serious AEs or clinically significant renal or hepatic safety changes were observed. Dose adjustment of CSL112 is not required in subjects with moderate RI, supporting its further investigation in AMI patients with moderate RI." @default.
• W2893062761 created "2018-10-05" @default.
• W2893062761 creator A5003187606 @default.
• W2893062761 creator A5012737319 @default.
• W2893062761 creator A5013142762 @default.
• W2893062761 creator A5030855173 @default.
• W2893062761 creator A5040437391 @default.
• W2893062761 creator A5054954472 @default.
• W2893062761 creator A5076210539 @default.
• W2893062761 creator A5083196007 @default.
• W2893062761 date "2018-09-21" @default.
• W2893062761 modified "2023-10-01" @default.
• W2893062761 title "Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function" @default.
• W2893062761 cites W1653290827 @default.
• W2893062761 cites W2008062676 @default.
• W2893062761 cites W2024440453 @default.
• W2893062761 cites W2082069148 @default.
• W2893062761 cites W2083446323 @default.
• W2893062761 cites W2097104644 @default.
• W2893062761 cites W2120972109 @default.
• W2893062761 cites W2141288916 @default.
• W2893062761 cites W2145536420 @default.
• W2893062761 cites W2154023449 @default.
• W2893062761 cites W2155965977 @default.
• W2893062761 cites W2169252817 @default.
• W2893062761 cites W2274989089 @default.
• W2893062761 cites W2549082007 @default.
• W2893062761 cites W2607031541 @default.
• W2893062761 doi "https://doi.org/10.1002/cpdd.618" @default.
• W2893062761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6618313" @default.
• W2893062761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30240132" @default.
• W2893062761 hasPublicationYear "2018" @default.
• W2893062761 type Work @default.
• W2893062761 sameAs 2893062761 @default.
• W2893062761 citedByCount "13" @default.
• W2893062761 countsByYear W28930627612018 @default.
• W2893062761 countsByYear W28930627612019 @default.
• W2893062761 countsByYear W28930627612020 @default.
• W2893062761 countsByYear W28930627612021 @default.
• W2893062761 countsByYear W28930627612022 @default.
• W2893062761 countsByYear W28930627612023 @default.
• W2893062761 crossrefType "journal-article" @default.
• W2893062761 hasAuthorship W2893062761A5003187606 @default.
• W2893062761 hasAuthorship W2893062761A5012737319 @default.
• W2893062761 hasAuthorship W2893062761A5013142762 @default.
• W2893062761 hasAuthorship W2893062761A5030855173 @default.
• W2893062761 hasAuthorship W2893062761A5040437391 @default.
• W2893062761 hasAuthorship W2893062761A5054954472 @default.
• W2893062761 hasAuthorship W2893062761A5076210539 @default.
• W2893062761 hasAuthorship W2893062761A5083196007 @default.
• W2893062761 hasBestOaLocation W28930627611 @default.
• W2893062761 hasConcept C112705442 @default.
• W2893062761 hasConcept C126322002 @default.
• W2893062761 hasConcept C126894567 @default.
• W2893062761 hasConcept C134018914 @default.
• W2893062761 hasConcept C142724271 @default.
• W2893062761 hasConcept C159641895 @default.
• W2893062761 hasConcept C197934379 @default.
• W2893062761 hasConcept C204787440 @default.
• W2893062761 hasConcept C27081682 @default.
• W2893062761 hasConcept C2778163477 @default.
• W2893062761 hasConcept C500558357 @default.
• W2893062761 hasConcept C62746215 @default.
• W2893062761 hasConcept C71924100 @default.
• W2893062761 hasConceptScore W2893062761C112705442 @default.
• W2893062761 hasConceptScore W2893062761C126322002 @default.
• W2893062761 hasConceptScore W2893062761C126894567 @default.
• W2893062761 hasConceptScore W2893062761C134018914 @default.
• W2893062761 hasConceptScore W2893062761C142724271 @default.
• W2893062761 hasConceptScore W2893062761C159641895 @default.
• W2893062761 hasConceptScore W2893062761C197934379 @default.
• W2893062761 hasConceptScore W2893062761C204787440 @default.
• W2893062761 hasConceptScore W2893062761C27081682 @default.
• W2893062761 hasConceptScore W2893062761C2778163477 @default.
• W2893062761 hasConceptScore W2893062761C500558357 @default.
• W2893062761 hasConceptScore W2893062761C62746215 @default.
• W2893062761 hasConceptScore W2893062761C71924100 @default.
• W2893062761 hasFunder F4320310420 @default.
• W2893062761 hasIssue "5" @default.
• W2893062761 hasLocation W28930627611 @default.
• W2893062761 hasLocation W28930627612 @default.
• W2893062761 hasLocation W28930627613 @default.
• W2893062761 hasLocation W28930627614 @default.
• W2893062761 hasOpenAccess W2893062761 @default.
• W2893062761 hasPrimaryLocation W28930627611 @default.
• W2893062761 hasRelatedWork W1966967166 @default.
• W2893062761 hasRelatedWork W1981345773 @default.
• W2893062761 hasRelatedWork W1999568358 @default.
• W2893062761 hasRelatedWork W2025648868 @default.
• W2893062761 hasRelatedWork W2072880852 @default.
• W2893062761 hasRelatedWork W2081377436 @default.
• W2893062761 hasRelatedWork W2088092754 @default.
• W2893062761 hasRelatedWork W2117255531 @default.
• W2893062761 hasRelatedWork W2418228134 @default.
• W2893062761 hasRelatedWork W2495016602 @default.
• W2893062761 hasVolume "8" @default.
• W2893062761 isParatext "false" @default.
• W2893062761 isRetracted "false" @default.

• next